- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CANO HEALTH Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 302,80 | -0,13 % | UnitedHealth Group Aktie steigt nach starken Quartalszahlen | ||
| INTUITIVE SURGICAL | 411,80 | +0,09 % | Intuitive Surgical: Warum der 40er-KGV Anlegern den Blick auf das wahre 10-Jahres-Potenzial verstellt | Intuitive Surgical steht trotz eines scheinbar ambitionierten 40er-KGV im Fokus langfristig orientierter Investoren. Der von Seeking Alpha analysierte Investment Case rückt weniger die aktuelle Bewertung... ► Artikel lesen | |
| THERMO FISHER | 399,90 | -0,22 % | Qualitätsaktie: Thermo Fisher: Aktie des Laborausrüsters vor bewegenden Zeiten! | © Foto: Sebastian Gollnow/dpaThermo Fisher: Die Aktie des US-amerikanischen Unternehmens kommt einfach nicht vom Fleck. Können da die Earnings helfen?Die Aktie von Thermo Fisher tut sich momentan schwer.... ► Artikel lesen | |
| ROKU | 97,74 | -0,59 % | The Only Reason to Consider Owning Roku for Less Than 3 Years | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update | SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| CENTENE | 34,830 | -2,41 % | Will Declining Memberships Weigh on Centene's Q1 Earnings? | ||
| QUIDELORTHO | 9,854 | -0,32 % | QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics | - Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagnostics -- Expands Portfolio with Ultra-Fast PCR Platform Designed to Deliver Results in Approximately... ► Artikel lesen | |
| VERU | 2,350 | +2,62 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,790 | -0,56 % | Tempest Therapeutics: Tempest Reports Year End 2025 Financial Results and Provides Business Update | Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing... ► Artikel lesen | |
| NANO-X IMAGING | 1,735 | +1,46 % | NANO-X IMAGING LTD: Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years | Howard's nationwide reach across healthcare and public sector markets expands Nanox's U.S. channel partner network to additional customer segments
PETAH TIKVA, Israel, April 20, 2026 -- Nano-X Imaging... ► Artikel lesen | |
| FULGENT GENETICS | 13,800 | -1,43 % | Fulgent Genetics completes $56.9M pathology lab acquisitions | ||
| LANTHEUS | 71,70 | -0,28 % | Here is Why Lantheus Holdings Inc (LNTH) Is Among the Best Medical AI Stocks to Invest In | ||
| PERSPECTIVE THERAPEUTICS | 3,930 | +1,97 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Several Upcoming Corporate Updates | SEATTLE, April 24, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 17,100 | +4,91 % | AMN Healthcare Services Inc: AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results | Quarterly revenue of $748 million- GAAP loss of ($0.20)/share and adjusted EPS of $0.22DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator... ► Artikel lesen |
Das Unternehmen CANO HEALTH INC kann der Branche Gesundheitswesen zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANO HEALTH INC finden Sie auf Wallstreet Online.